Berthold Koletzko

Summary

Country: Germany

Publications

  1. Theurich M, Weikert C, Abraham K, Koletzko B. [Breastfeeding rate and promotion in selected European countries]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:926-936 pubmed publisher
  2. Kirchberg F, Werkstetter K, Uhl O, Auricchio R, Castillejo G, Korponay Szabo I, et al. Investigating the early metabolic fingerprint of celiac disease - a prospective approach. J Autoimmun. 2016;72:95-101 pubmed publisher
    ..Our results suggest that metabolic pathways reflected in serum are affected only later in life and that the HLA-genotype does not influence the serum metabolic profile in young infants before introduction of solid food. ..
  3. Maier F, Demmelmair H, Fugmann M, Hellmuth C, Lechner A, Koletzko B, et al. Contribution of glycerophospholipids and sphingomyelin to the circulating NEFA. Prostaglandins Leukot Essent Fatty Acids. 2016;110:55-61 pubmed publisher
    ..The NEFA composition varied highly between fasting and fed state in both groups. GPL appeared to contribute long-chain polyunsaturated fatty acid, while SM appeared to contribute very long-chain fatty acids to the NEFA pool. ..
  4. Hellmuth C, Uhl O, Kirchberg F, Harder U, Peissner W, Koletzko B, et al. Influence of moderate maternal nutrition restriction on the fetal baboon metabolome at 0.5 and 0.9 gestation. Nutr Metab Cardiovasc Dis. 2016;26:786-96 pubmed publisher
    ..Decreased concentrations of AA suggest an up-regulation of gluconeogenesis in MNR. ..
  5. Bischoff S, Boirie Y, Cederholm T, Chourdakis M, Cuerda C, Delzenne N, et al. Towards a multidisciplinary approach to understand and manage obesity and related diseases. Clin Nutr. 2017;36:917-938 pubmed publisher
  6. Drzymała Czyż S, Krzyżanowska P, Koletzko B, Nowak J, Miśkiewicz Chotnicka A, Moczko J, et al. Determinants of Serum Glycerophospholipid Fatty Acids in Cystic Fibrosis. Int J Mol Sci. 2017;18: pubmed publisher
    ..They seem to be caused by both metabolic disturbances and independent clinical risk factors. Further research into the influence of CFTR mutations on fat metabolism and desaturases' activity is warranted. ..
  7. Koletzko B. Should Women Providing Milk to Their Preterm Infants Take Docosahexaenoic Acid Supplements?. Clin Perinatol. 2017;44:85-93 pubmed publisher
    ..Possibly subgroups of preterm infants achieve greater benefits as well as infants with genotypes predicting a low rate of endogenous long-chain polyunsaturated fatty acids formation. ..
  8. Drzymała Czyż S, Janich S, Klingler M, Demmelmair J, Walkowiak J, Koletzko B. Whole blood glycerophospholipids in dried blood spots - a reliable marker for the fatty acid status. Chem Phys Lipids. 2017;207:1-9 pubmed publisher
    ..3%±1.6). Whole blood GPL fatty acids are a robust biological marker for the fatty acid status of fasted and non-fasted subjects. The influence of very recent dietary intake on whole blood GPL is smaller than on whole blood total lipids. ..
  9. Segura M, Demmelmair H, Krauss Etschmann S, Nathan P, Dehmel S, Padilla M, et al. Maternal BMI and gestational diabetes alter placental lipid transporters and fatty acid composition. Placenta. 2017;57:144-151 pubmed publisher
    ..Our results demonstrate that high pre-pregnancy BMI or GDM independently alter mRNA expression levels of genes involved in FA uptake and metabolism and the placental FA profile, which could affect fetal development and long-term health. ..